{"id":84143,"date":"2022-06-14T22:13:43","date_gmt":"2022-06-14T22:13:43","guid":{"rendered":"https:\/\/ergclinical.com\/?p=84143"},"modified":"2022-06-14T22:13:43","modified_gmt":"2022-06-14T22:13:43","slug":"evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities","status":"publish","type":"post","link":"https:\/\/ergclinical.com\/es\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/","title":{"rendered":"Evolution Research Group, LLC adquiere Ohio Clinical Trials, LLC y ampl\u00eda a\u00fan m\u00e1s sus capacidades de servicios de desarrollo en etapa temprana y farmacolog\u00eda cl\u00ednica"},"content":{"rendered":"

NOTICIAS PROPORCIONADAS POR<\/p>\n

Grupo de investigaci\u00f3n sobre la evoluci\u00f3n, LLC\u00a0<\/strong><\/a><\/p>\n

7 de junio de 2022, 08:22 ET<\/p>\n

 <\/p>\n

NEW PROVIDENCE, NJ, 7 de junio de 2022 \/PRNewswire\/ -- Evolution Research Group, LLC (ERG), un proveedor de servicios farmac\u00e9uticos independiente y de capital privado centrado en la neurociencia, anunci\u00f3 la adquisici\u00f3n de Ohio Clinical Trials (OCT), una unidad de fase 1 de 64 camas en Columbus, Ohio, que se especializa en la ejecuci\u00f3n de estudios de potencial de abuso humano (HAP), as\u00ed como otros ensayos de fase temprana altamente complejos que incluyen modelado del dolor, qEEG\/EEG, depresi\u00f3n respiratoria e interacci\u00f3n con el alcohol, entre otros.<\/p>\n

Glen Apseloff, MD, fundador e investigador principal, tiene m\u00e1s de 30 a\u00f1os de experiencia en el dise\u00f1o y ejecuci\u00f3n de estudios farmacol\u00f3gicos cl\u00ednicos complejos. Como director de farmacolog\u00eda cl\u00ednica en el Departamento de farmacolog\u00eda de la Facultad de medicina de la Universidad Estatal de Ohio (OSU) durante m\u00e1s de una d\u00e9cada, el Dr. Apseloff fue responsable de todas las operaciones de ensayos cl\u00ednicos de fase 1. En 2012, cuando las prioridades de investigaci\u00f3n de la OSU cambiaron a otras \u00e1reas, pudo trasladar la unidad, junto con su personal altamente capacitado, para formar OCT.<\/p>\n

Esta adquisici\u00f3n permite al Dr. Apseloff centrarse principalmente en sus responsabilidades de investigador principal, mientras que la infraestructura l\u00edder en la industria de ERG respalda los aspectos cl\u00ednicos, tecnol\u00f3gicos y de calidad de las operaciones del sitio, al mismo tiempo que absorbe todas las responsabilidades financieras y de recursos humanos. El Dr. Apseloff dijo: "Estoy encantado de ser parte de la familia de sitios de ERG. Esto me permitir\u00e1 concentrarme m\u00e1s en el dise\u00f1o y la ejecuci\u00f3n de ensayos cl\u00ednicos mientras ERG administra los aspectos comerciales. Tambi\u00e9n espero trabajar con su personal de soporte centralizado y su equipo cl\u00ednico m\u00f3vil que ayuda con los desaf\u00edos log\u00edsticos. Ojal\u00e1 hubiera tenido este tipo de soporte antes".<\/p>\n

La adquisici\u00f3n de OCT respalda la estrategia de ERG de seguir sumando talento y servicios para diversificarse a\u00fan m\u00e1s en las \u00e1reas de neurociencia y terapia del dolor, as\u00ed como para agilizar la ejecuci\u00f3n de ensayos cl\u00ednicos en todas las fases de desarrollo. \u201cConozco al Dr. Apseloff desde hace muchos a\u00f1os y estoy encantada de haber podido concretar este acuerdo en un momento en el que nuestros clientes exigen los tipos de estudios que \u00e9l ha estado realizando con \u00e9xito durante d\u00e9cadas. Es un farmac\u00f3logo cl\u00ednico brillante y un investigador principal muy involucrado, y las capacidades que ha desarrollado complementan muy bien las de nuestras otras unidades de fase inicial\u201d, afirm\u00f3 Lori Wright, presidenta y directora ejecutiva de ERG.<\/p>\n

Obtenga m\u00e1s informaci\u00f3n sobre ERG visitando\u00a0www.ergclinical.com<\/a><\/p>\n

Acerca de Evolution Research Group
\n<\/strong>Evolution Research Group, LLC es una subsidiaria de ERG Holding Company, que incluye veinte CRU de propiedad y operaci\u00f3n absoluta, una red establecida de sitios de investigaci\u00f3n cl\u00ednica afiliados, Lotus Clinical Research, LLC, una CRO de servicio completo, y CNS Ratings, LLC, una empresa de capacitaci\u00f3n, vigilancia y consultor\u00eda de evaluadores. ERG lleva a cabo una amplia gama de ensayos simples y altamente complejos en poblaciones especializadas, incluidas aquellas que padecen trastornos psiqui\u00e1tricos y neurol\u00f3gicos, dolor agudo y cr\u00f3nico, trastornos del sue\u00f1o, adicciones, NASH\/NAFLD, trastornos metab\u00f3licos y endocrinol\u00f3gicos, entre otros, as\u00ed como en voluntarios sanos normales.<\/p>\n

CONTACTO CON LOS MEDIOS: Mackie Wright,\u00a0mwright@ergclinical.com<\/a><\/p>\n

FUENTE Evolution Research Group, LLC<\/p>","protected":false},"excerpt":{"rendered":"

NEWS PROVIDED BY Evolution Research Group, LLC\u00a0 Jun 07, 2022, 08:22 ET   NEW\u00a0PROVIDENCE, N.J.,\u00a0June 7, 2022\u00a0\/PRNewswire\/ — Evolution Research […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[82],"tags":[],"class_list":["post-84143","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"\nEvolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities - ERG Clinical<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ergclinical.com\/es\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities - ERG Clinical\" \/>\n<meta property=\"og:description\" content=\"NEWS PROVIDED BY Evolution Research Group, LLC\u00a0 Jun 07, 2022, 08:22 ET   NEW\u00a0PROVIDENCE, N.J.,\u00a0June 7, 2022\u00a0\/PRNewswire\/ — Evolution Research […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ergclinical.com\/es\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/\" \/>\n<meta property=\"og:site_name\" content=\"ERG Clinical\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-14T22:13:43+00:00\" \/>\n<meta name=\"author\" content=\"dhennessy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"dhennessy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/\"},\"author\":{\"name\":\"dhennessy\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#\\\/schema\\\/person\\\/0ea9f2436c83498cfbd1162dc0fc1e8f\"},\"headline\":\"Evolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities\",\"datePublished\":\"2022-06-14T22:13:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/\"},\"wordCount\":501,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/\",\"url\":\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/\",\"name\":\"Evolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities - ERG Clinical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#website\"},\"datePublished\":\"2022-06-14T22:13:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ergclinical.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#website\",\"url\":\"https:\\\/\\\/ergclinical.com\\\/\",\"name\":\"ERG Clinical\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ergclinical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#organization\",\"name\":\"ERG Clinical\",\"url\":\"https:\\\/\\\/ergclinical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ergclinical.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/erg-site-icon-512-lt.png\",\"contentUrl\":\"https:\\\/\\\/ergclinical.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/erg-site-icon-512-lt.png\",\"width\":512,\"height\":512,\"caption\":\"ERG Clinical\"},\"image\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#\\\/schema\\\/person\\\/0ea9f2436c83498cfbd1162dc0fc1e8f\",\"name\":\"dhennessy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1d3f9ebe21e06fc46dc6119017222fd15cc4727794350c5b1b35604b681e686b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1d3f9ebe21e06fc46dc6119017222fd15cc4727794350c5b1b35604b681e686b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1d3f9ebe21e06fc46dc6119017222fd15cc4727794350c5b1b35604b681e686b?s=96&d=mm&r=g\",\"caption\":\"dhennessy\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evolution Research Group, LLC adquiere Ohio Clinical Trials, LLC y ampl\u00eda a\u00fan m\u00e1s sus capacidades de servicios de farmacolog\u00eda cl\u00ednica y desarrollo en etapa temprana - ERG Clinical","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ergclinical.com\/es\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/","og_locale":"es_MX","og_type":"article","og_title":"Evolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities - ERG Clinical","og_description":"NEWS PROVIDED BY Evolution Research Group, LLC\u00a0 Jun 07, 2022, 08:22 ET   NEW\u00a0PROVIDENCE, N.J.,\u00a0June 7, 2022\u00a0\/PRNewswire\/ — Evolution Research […]","og_url":"https:\/\/ergclinical.com\/es\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/","og_site_name":"ERG Clinical","article_published_time":"2022-06-14T22:13:43+00:00","author":"dhennessy","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"dhennessy","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/#article","isPartOf":{"@id":"https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/"},"author":{"name":"dhennessy","@id":"https:\/\/ergclinical.com\/#\/schema\/person\/0ea9f2436c83498cfbd1162dc0fc1e8f"},"headline":"Evolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities","datePublished":"2022-06-14T22:13:43+00:00","mainEntityOfPage":{"@id":"https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/"},"wordCount":501,"commentCount":0,"publisher":{"@id":"https:\/\/ergclinical.com\/#organization"},"articleSection":["News"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/","url":"https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/","name":"Evolution Research Group, LLC adquiere Ohio Clinical Trials, LLC y ampl\u00eda a\u00fan m\u00e1s sus capacidades de servicios de farmacolog\u00eda cl\u00ednica y desarrollo en etapa temprana - ERG Clinical","isPartOf":{"@id":"https:\/\/ergclinical.com\/#website"},"datePublished":"2022-06-14T22:13:43+00:00","breadcrumb":{"@id":"https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ergclinical.com\/evolution-research-group-llc-acquires-ohio-clinical-trials-llc-further-expanding-clinical-pharmacology-early-stage-development-service-capabilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ergclinical.com\/"},{"@type":"ListItem","position":2,"name":"Evolution Research Group, LLC Acquires Ohio Clinical Trials, LLC Further Expanding Clinical Pharmacology & Early Stage Development Service Capabilities"}]},{"@type":"WebSite","@id":"https:\/\/ergclinical.com\/#website","url":"https:\/\/ergclinical.com\/","name":"ERG Cl\u00ednico","description":"","publisher":{"@id":"https:\/\/ergclinical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ergclinical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ergclinical.com\/#organization","name":"ERG Cl\u00ednico","url":"https:\/\/ergclinical.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ergclinical.com\/#\/schema\/logo\/image\/","url":"https:\/\/ergclinical.com\/wp-content\/uploads\/2019\/05\/erg-site-icon-512-lt.png","contentUrl":"https:\/\/ergclinical.com\/wp-content\/uploads\/2019\/05\/erg-site-icon-512-lt.png","width":512,"height":512,"caption":"ERG Clinical"},"image":{"@id":"https:\/\/ergclinical.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ergclinical.com\/#\/schema\/person\/0ea9f2436c83498cfbd1162dc0fc1e8f","name":"Dennessy","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/1d3f9ebe21e06fc46dc6119017222fd15cc4727794350c5b1b35604b681e686b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1d3f9ebe21e06fc46dc6119017222fd15cc4727794350c5b1b35604b681e686b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1d3f9ebe21e06fc46dc6119017222fd15cc4727794350c5b1b35604b681e686b?s=96&d=mm&r=g","caption":"dhennessy"}}]}},"_links":{"self":[{"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/posts\/84143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/comments?post=84143"}],"version-history":[{"count":0,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/posts\/84143\/revisions"}],"wp:attachment":[{"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/media?parent=84143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/categories?post=84143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/tags?post=84143"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}